AAAAAA

   
Results: 1-13 |
Results: 13
Polymorphisms of the repeated sequences in the enhancer region of the thymidylate synthase gene promoter may predict downstaging after preoperative chemoradiation in rectal cancer
Authors: Villafranca, E Okruzhnov, Y Dominguez, MA Garcia-Foncillas, J Azinovic, I Martinez, E Ilarramendi, JJ Arias, F Monge, RM Salgado, E Angeletti, S Brugarolas, A
Citation: E. Villafranca et al., Polymorphisms of the repeated sequences in the enhancer region of the thymidylate synthase gene promoter may predict downstaging after preoperative chemoradiation in rectal cancer, J CL ONCOL, 19(6), 2001, pp. 1779-1786
Mobilization of hematopoietic progenitor cells with a combination of docetaxel, adriamycin, 5-fluorouracil and filgrastim in breast cancer patients
Authors: Perez-Calvo, J Fernandez-Hidalgo, O Subira, ML Martin-Algarra, S Salgado, E Brugarolas, A
Citation: J. Perez-calvo et al., Mobilization of hematopoietic progenitor cells with a combination of docetaxel, adriamycin, 5-fluorouracil and filgrastim in breast cancer patients, HAEMATOLOG, 86(1), 2001, pp. 100-101
Multiple cycles of dose-intensive chemotherapy with repeated stem cell support as induction treatment in metastatic breast cancer: a feasibility study
Authors: Garcia-Rayo, S Perez-Calvo, J Martin-Algarra, S Martinez-Monge, R Fernandez-Hidalgo, O Subira, L Martinez-Aguillo, M Rebollo, J Azinovic, I Brugarolas, A
Citation: S. Garcia-rayo et al., Multiple cycles of dose-intensive chemotherapy with repeated stem cell support as induction treatment in metastatic breast cancer: a feasibility study, BONE MAR TR, 28(3), 2001, pp. 235-242
Fixed higher dose schedule of suramin plus hydrocortisone in patients withhormone refractory prostate carcinoma - A multicenter phase II study
Authors: Calvo, E Cortes, J Rodriguez, J Sureda, M Beltran, U Rebollo, J Martinez-Monge, R Berian, JM de Irala, J Brugarolas, A
Citation: E. Calvo et al., Fixed higher dose schedule of suramin plus hydrocortisone in patients withhormone refractory prostate carcinoma - A multicenter phase II study, CANCER, 92(9), 2001, pp. 2435-2443
Factors determining the actual received dose intensity in a program of multicyclic dose-intensive alternating chemotherapy with sequential stem cell support
Authors: Perez-Calvo, J Martinez-Aguillo, M Garcia-Rayo, S Cajal, TRY Santisteban, M Ordonez, JM Inoges, S Subira, ML Martin-Algarra, S Brugarolas, A
Citation: J. Perez-calvo et al., Factors determining the actual received dose intensity in a program of multicyclic dose-intensive alternating chemotherapy with sequential stem cell support, ACT HAEMAT, 105(3), 2001, pp. 137-142
Epoch-cyclosporin A induces high response rates in relapsed lymphomas
Authors: Lopez-Picazo, JM Manzano, RG Tres, JMO Jimenez, MM Calvo, JP Brugarolas, A
Citation: Jm. Lopez-picazo et al., Epoch-cyclosporin A induces high response rates in relapsed lymphomas, HAEMATOLOG, 85(9), 2000, pp. 1003-1004
Effects of hepatic function on vancomycin pharmacokinetics in patients with cancer
Authors: Aldaz, A Ortega, A Idoate, A Giraldez, J Brugarolas, A
Citation: A. Aldaz et al., Effects of hepatic function on vancomycin pharmacokinetics in patients with cancer, THER DRUG M, 22(3), 2000, pp. 250-257
Paclitaxel, cisplatin, and gemcitabine combination chemotherapy within a multidisciplinary therapeutic approach in metastatic nonsmall cell lung carcinoma - A Phase II study
Authors: Rodriguez, J Cortes, J Calvo, E Azinovic, I Fernandez-Hildago, O Martinez-Monge, R Garzon, C de Irala, J Martinez-Aguillo, M Cajal, TRY Brugarolas, A
Citation: J. Rodriguez et al., Paclitaxel, cisplatin, and gemcitabine combination chemotherapy within a multidisciplinary therapeutic approach in metastatic nonsmall cell lung carcinoma - A Phase II study, CANCER, 89(12), 2000, pp. 2622-2629
Relationship between pharmacokinetic parameters of gentamicin and patient characteristics and/or clinical data in patients with solid organ tumours
Authors: Ortega, A Aldaz, A Giraldez, J Brugarolas, A
Citation: A. Ortega et al., Relationship between pharmacokinetic parameters of gentamicin and patient characteristics and/or clinical data in patients with solid organ tumours, PHARM WORLD, 21(5), 1999, pp. 227-232
Induction platinum-based chemotherapy followed by radical hyperfractionated radiotherapy with concurrent chemotherapy in the treatment of locally advanced non-small-cell carcinoma of the lung
Authors: Lopez-Picazo, JM Azinovic, I Aristu, JJ Monge, RM Jimenez, MM Aller, EC Beltran, C Aramendia, JM Rebollo, J Brugarolas, A
Citation: Jm. Lopez-picazo et al., Induction platinum-based chemotherapy followed by radical hyperfractionated radiotherapy with concurrent chemotherapy in the treatment of locally advanced non-small-cell carcinoma of the lung, AM J CL ONC, 22(2), 1999, pp. 203-208
Pilot study of concurrent cisplatin, 5-fluorouracil, and external beam radiotherapy prior to radical surgery +/- intraoperative electron beam radiotherapy in locally advanced cervical cancer
Authors: Jurado, M Martinez-Monge, R Garcia-Foncillas, J Azinovic, I Aristu, J Lopez-Garcia, G Brugarolas, A
Citation: M. Jurado et al., Pilot study of concurrent cisplatin, 5-fluorouracil, and external beam radiotherapy prior to radical surgery +/- intraoperative electron beam radiotherapy in locally advanced cervical cancer, GYNECOL ONC, 74(1), 1999, pp. 30-37
Treatment of acute myeloid leukemia
Authors: Perez-Calvo, J Brugarolas, A
Citation: J. Perez-calvo et A. Brugarolas, Treatment of acute myeloid leukemia, N ENG J MED, 340(18), 1999, pp. 1436-1436
Value of PET-(18)FDG in lung cancer
Authors: Richter, JA Torre, W Gamez, C Aramendia, JM Crespo, A Nicolas, A Brugarolas, A
Citation: Ja. Richter et al., Value of PET-(18)FDG in lung cancer, MED CLIN, 113(15), 1999, pp. 567-571
Risultati: 1-13 |